← Eichor
Study identifier: NCT06419374 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Condition: Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis  ·  Sponsor: 89bio, Inc.

PhasePhase 3
Planned participants762
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalcoholic steatohepatitis, NASH\]).

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: BIO89-100-132 ENLIGHTEN clinical trial / No attachments to email below.  ·  888-662-6728 (U.S. Only)  ·  global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (317)

89bio Clinical Study SiteBirmingham, Alabama, United StatesRecruiting
89bio Clinical Study SiteHomewood, Alabama, United StatesRecruiting
89bio Clinical Study SiteChandler, Arizona, United StatesRecruiting
89bio Clinical Study SiteFlagstaff, Arizona, United StatesWithdrawn
89bio Clinical Study SitePeoria, Arizona, United StatesRecruiting
89bio Clinical Study SitePhoenix, Arizona, United StatesRecruiting
89bio Clinical Study SiteSun City, Arizona, United StatesRecruiting
89bio Clinical Study SiteTucson, Arizona, United StatesRecruiting
89bio Clinical Study SiteTucson, Arizona, United StatesRecruiting
89bio Clinical Study SiteTucson, Arizona, United StatesRecruiting
89bio Clinical Study SiteLittle Rock, Arkansas, United StatesRecruiting
89bio Clinical Study SiteNorth Little Rock, Arkansas, United StatesRecruiting

+ 305 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06419374